GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in medical research, largely due to its remarkable impact on controlling conditions such as second type diabetes and weight gain. Recent research have shown that in addition to glucose management, GLP-1 agonists offer benefits for cardiovascular well